key: cord-0931422-x7k9f0pm authors: Biswas, Jyotirmay; Kandle, Kaustubh title: Does ocular tissue contain SARS CoV-2? date: 2021-09-03 journal: Indian J Ophthalmol DOI: 10.4103/ijo.ijo_1932_21 sha: 640475752c4b8a3d6471f9a411cc40d892b0b6c8 doc_id: 931422 cord_uid: x7k9f0pm nan In the SARS CoV-2 infection, virus shedding is highest in the earliest stage. Asymptomatic carriers of SARS CoV-2 are of particular risk to ophthalmologists during examination. Specialists are at higher risk of infection, particularly anesthesiologist and otorhinolaryngologist, who are routinely exposed to aerosolized respiratory secretions and nasopharyngeal procedures. [1] The ocular findings of SARS CoV-2 infection described so far include conjunctivitis, episcleritis, anterior uveitis, panuveitis, flame-shaped retinal hemorrhage, cotton wool spots, COVID-19-associated retinopathy, retinal vascular occlusions, papillophlebitis, and panuveitis. [4] Recent studies have shown that viral RNA has been isolated from conjunctiva, tear film in <1% cases in patients who had conjunctivitis. Viral RNA has not been identified in the tear film of COVID-19 patients without conjunctivitis till date, but data representing sampling performed early in the disease course when viral load is highest are lacking. [1] List et al. [3] in their study included 16 aqueous samples and 16 vitreous samples for PCR testing form individuals who were previously positive in nasopharyngeal swabbing, and the cause of death was respiratory failure due to SARS CoV-2 infection. All the samples were negative for SARS CoV-2. Saiegh et al. [5] in their short report of two patients who tested positive for COVID-19 on nasal swab with central nervous system involvement were negative for cerebrospinal fluid RT-PCR for COVID-19. One patient had subarachnoid hemorrhage and the second patient had an ischemic stroke with massive hemorrhagic conversion. The authors concluded that the underlying inflammatory and hypercoagulable state might incite cerebrovascular disease without disruption of blood brain barrier. Koo et al. [6] found SARS CoV-2 viral RNA in aqueous despite negative nasal swab testing. This showed the presence of SARS CoV-2 virus beyond the blood-ocular barrier in asymptomatic individuals. So, the possibility of the virus persisting in immunoprivileged spaces despite absence of symptoms cannot be denied. In a study conducted by Sawant et al. [7] on postmortem ocular tissues, there was 13% positivity rate for SARS CoV-2 in 132 ocular tissues included in this study. The highest prevalence of SARS CoV-2 RNA was noted in the posterior corneal endothelial surface as compared to any other ocular tissue swabs. They found that none of the iris sample showed SARS CoV-2 RNA on RTPCR. They also detected SARS CoV-2 RNA in 2 of the 20 vitreous swabs. They recommended postmortem PCR testing in donors, 5% povidone iodine disinfection protocol, and thorough donor screening to prevent the potential risk of transplanting a tissue with SARS CoV-2 particles. A study by Casagrande et al. [8] showed 21% prevalence rate of SARS CoV-2 RNA in retinal biopsy from 14 eyes of 14 deceased COVID-19 patients. Araujo-Silva CA et al in a recent paper published in July 2021 showed presumed SARS-CoV-2 viral particles in various layers of the human retina, suggesting that they may be involved in some of the infection's ocular clinical manifestations. [9] There are conflicting reports of isolation of SARS CoV-2 RNA from various ocular tissues. Therefore, the role of the eye as a route of infection is yet to be proved. Authors in the present study did not find SARS CoV-2 RNA in the aqueous fluid and vitreous aspirate who had undergone surgery following trauma. Although it is a key finding, the number of cases is less and the patients had mild to asymptomatic presentation. So, a study with a larger sample size is important. [10] At the present scenario, consensus guidelines for various aerosol-generating ocular procedures like phacoemulsification, glaucoma surgeries, vitreoretinal surgeries, and periocular procedures to prevent COVID-19 have been described in the literature and should be continued to be followed in the future to minimize the risk of transmission of SARS CoV-2 virus. [11] [12] [13] [14] [15] Preparedness among ophthalmologists: During and beyond the COVID-19 pandemic Occurrence of SARS-CoV-2 in the intraocular milieu Bilateral post fever retinitis with retinal vascular occlusions following severe acute respiratory syndrome corona virus (SARS-CoV2) infection Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke Presence of SARS-CoV-2 viral RNA in aqueous humor of asymptomatic individuals Prevalence of SARS-CoV-2 in human post-mortem ocular tissues Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19 Evaluating the presence of SARS-CoV-2 in the intraocular fluid of COVID-19 patients All India Ophthalmological Society -Oculoplastics Association of India consensus statement on preferred practices in oculoplasty and lacrimal surgery during the COVID-19 pandemic Evolving consensus on managing vitreo-retina and uvea practice in post-COVID-19 pandemic era Preferred practice guidelines for glaucoma management during COVID-19 pandemic All India Ophthalmological Society -Indian Journal of Ophthalmology consensus statement on preferred practices during the COVID-19 pandemic COVID-19: Limiting the risks for eye care professionals Cite this article as: Biswas J, Kandle K. Does ocular tissue contain SARS CoV-2? This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Currently, Prof Biswas is the Director of uveitis and ophthalmic pathology departments at Sankara Nethralaya, Chennai.